MedTech Acquisition, operating as TriSalus Life Sciences, Inc., recently filed an 8-K report with the Securities and Exchange Commission (SEC) on November 14, 2024. In the filing, the company provided ...
TriSalus Life Sciences Inc., (Nasdaq: TLSI), an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, today ...
Q3 2024 Earnings Call Transcript November 14, 2024 TriSalus Life Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.36. Operator: Good morning, and ...
TriSalus Life Sciences, Inc. ( NASDAQ: TLSI) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Jim Young - Senior Vice President, Investor Relations & Treasurer Mary Szela - President & ...
Fast food chains like McDonalds, Starbucks, Burger King, and Dunkin are often flagged as unhealthy, especially for ...